Your browser doesn't support javascript.
loading
The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice.
Choi, Jeong A; Chung, Yoo-Ri; Byun, Hyae-Ran; Park, Hwangseo; Koh, Jae-Young; Yoon, Young Hee.
  • Choi JA; Neural Injury Research Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Chung YR; Department of Ophthalmology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Byun HR; Neural Injury Research Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Park H; Department of Bioscience and Biotechnology, Sejong University, Seoul, Republic of Korea.
  • Koh JY; Neural Injury Research Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: jkko@amc.seoul.kr.
  • Yoon YH; Department of Ophthalmology, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: yhyoon@amc.seoul.kr.
Toxicol Appl Pharmacol ; 315: 80-89, 2017 Jan 15.
Article en En | MEDLINE | ID: mdl-27939241
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Riluzol / Pericitos / Retinopatía Diabética / Esclerosis Amiotrófica Lateral Límite: Animals Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Riluzol / Pericitos / Retinopatía Diabética / Esclerosis Amiotrófica Lateral Límite: Animals Idioma: En Año: 2017 Tipo del documento: Article